Thursday December 12th , 2024: Day ThreeThursday, 12 December 2024 - ET (Eastern Time, GMT-05:00)

• Look at the gross-to-net bubble across different product mixes, including generics, brand and biosimilars
• Align stakeholder needs, considering distribution network & market access and ensure company profitability
• Dive into pricing's role in access and WAC updates and guidelines

Gain insight in an exclusive breakdown of critical financial metrics influencing shareholder value creation. Explore the intricacies of enterprise value growth, enterprise value to sales ratios, and return on invested capital (ROIC) within the context of market dynamics and company strategies. Gain insights into the nuanced performance indices and understand how these metrics shape the landscape of the pharmaceutical industry in a data-rich session.

• Highlight how the HMO model is gaining traction in the industry
• Examine the approaches of major players such as Aetna, UnitedHealthcare, and Optum, as well as the efforts of Humana and Elevance in implementing vertical integration
• Gain insights into the benefits, challenges and future trends of this transformative approach in healthcare

• Explore how to maximize the potential of existing commercial structures and teams to secure assets with commercial potential
• Understand how to position your company to navigate future market volatility and events, ensuring long-term growth and stability
• Discover the benefits of forming strategic partnerships, joint ventures and alliances to drive growth and share risks in the pharmaceutical market